Login

Marie-France Courcoux

ORCID: 0000-0003-0637-4778
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5012915986
Research Areas
  • Heparin-Induced Thrombocytopenia and Thrombosis
  • Autoimmune Bullous Skin Diseases
  • Systemic Lupus Erythematosus Research
  • T-cell and B-cell Immunology
  • Healthcare Systems and Practices

Sorbonne Université
 2013-2017

Hôpital Armand-Trousseau
 2013-2017

Assistance Publique – Hôpitaux de Paris
 2017

 Autoimmune disorders and quadrivalent human papillomavirus vaccination of young female subjects
OPENALEX - Publications 
Lamiae Grimaldi‐Bensouda Didier Guillemot Bertrand Godeau Jacques Bénichou Christine Lebrun‐Frénay and 17 more Caroline Papeix Pierre Labauge Patrick Berquin A. Penfornis P.‐Y. Benhamou Marc Nicolino Albane Simon Jean‐François Viallard N. Costedoat‐Chalumeau Marie-France Courcoux Corinne Pondarré Pascal Hilliquin Emmanuel Chatelus Violaine Foltz Séverine Guillaume M Rossignol Lucien Abenhaim

Abstract Objectives The aim of this study was to investigate whether the quadrivalent human papillomavirus ( HPV ) vaccine Gardasil is associated with a change in risk autoimmune disorders AD s) young female subjects. Design Systematic case–control incident s vaccination women across France. Participants and setting A total 113 specialised centres recruited (from December 2007 April 2011) females aged 14–26 years cases six types s: idiopathic thrombocytopenic purpura ITP ), central...

10.1111/joim.12155 article EN Journal of Internal Medicine 2013-11-08
 Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance
OPENALEX - Publications 
Lamiae Grimaldi‐Bensouda Michel Rossignol Isabelle Koné-Paut A Krivitzky Christine Lebrun‐Frénay and 95 more Johanna Clet David Brassat Caroline Papeix Marc Nicolino Pierre‐Yves Benhamou Olivier Fain N. Costedoat‐Chalumeau Marie-France Courcoux Jean‐François Viallard Bertrand Godeau T. Papo Patrick Vermersch Isabelle Bourgault‐Villada Gérard Bréart Lucien Abenhaim Firas Abbas Abdelhakim Abdelmoumni Pascal Hilliquin E Requeda D. Adoué David Brassat C. Agard A. Masseau Nathalie Aladjidi Johanna Clet Helder Fernandes Gwendal Le Masson Yves Pérel Isabelle Raymond‐Letron Olivier Richer Anne Vital Emma Allain-Launay Marie Bru Marc Nicolino Caroline Thomas Jean‐Jacques Altman D. Amsallem Nazmiye Aras Latifato Boukari Marie Dubrel Olivier Fain E. Letellier Nadine Lucidarme A. Mékinian Anne‐Sophie Morin Jérôme Stirnemann Catherine Atlan Dominique Audry Jérôme Augustin Redouane Bakir Pablo Bartolucci Xavier Chevalier Bertrand Godeau Constance Guillaud Mehdi Khellaf Nicolas Limal Valentine Lousteau Matthieu Mahévas Gayané Meliksetyan Marc Michel Mathilde Roumier Sophie Bayart Fabrice Bonnet Olivier Decaux Amine Bekherraz B. Brihaye Roger Dachez Éric Daugas Gilles Hayem Olivier Meyer T. Papo E. Pasqualoni Karim Sacré F. Travert Hélène Bellon Jacques Beltrand François Lefrère Albane Simon Pierre‐Yves Benhamou Olivier Benveniste Françis Bolgert N. Costedoat‐Chalumeau Raphaël De Paz Sophie Demeret Bruno Fautrel Sophie Jacqueminet Céline Louapre E. Maillart N. Costedoat‐Chalumeau Caroline Papeix Julie Rigabert Philippe Bensaïd Claire Berger Patrick Berquin Anne-Gaëlle Le Moing

Safety of HPV vaccines is still in question due to reports autoimmune diseases (ADs) following immunization.To assess the risk ADs associated with vaccination female adolescents/young adults France.Systematic prospective case-referent study conducted risks real-life use vaccines. Cases were 11-25 years old incident [central demyelination/multiple sclerosis (CD/MS), connective tissue disease (CTD), Guillain-Barré syndrome (GBS), type-1 diabetes (T1D), thyroiditis (AT), and idiopathic...

10.1016/j.jaut.2017.01.005 article EN cc-by-nc-nd Journal of Autoimmunity 2017-02-09
Coming Soon ...